100% Same
Salt CompositionEffectivenessStrength
with Substitute Medicine
Salt Composition in bothYou Searched
Mycos-P Oral Suspension
LIncoln Pharmaceuticals Ltd.
₹20,990
Our Recommendation
Poscosafe 40mg Oral Suspension 105ml
Safecon Lifesciences
174+ trust this
WHO GMP Certified
WHO GMP
Certified
15 Days Easy
Returns
Long Expiry
(>8 Months)
WHO GMP
Certified
15 Days Easy
Returns
Long Expiry
(>8 Months)
Delivery by
Used In
Severe fungal infections
Customers also bought
More About Mycos-P
Benefits
In Severe fungal infections Mycos-P Oral Suspension is an antifungal medicine. It works by killing and stopping the growth of fungus that is causing the infection. It helps treat severe infections in severely immunocompromised patients, cancer patients, and those undergoing blood transfusion. The dose and duration of treatment will depend on what you are being treated for. Make sure you complete the full course of treatment. This will ensure that the infection is completely cured and prevent it from returning.
Side Effects
The majority of side effects typically do not necessitate medical intervention. and disappear as your body adjusts to the medicine. Doctor consultation is advised if they persist or if you're worried about them.
How to use
Follow your doctor's guidance regarding the dose and duration of this medication. Check the label for directions before use. Measure it with a measuring cup and take it by mouth. Shake well before use. Mycos-P Oral Suspension is to be taken with food.
How it works
Mycos-P Oral Suspension is an antifungal medication. It kills and stops the growth of the fungi by destroying its cell membrane, thereby treating your skin infection.
Consult your Doctor: Please consult your doctor regarding the safety of consuming alcohol with Mycos-P Oral Suspension . Experts have not found evidence of alcohol impairing the effectiveness of the medicine.
Seek medical advice from your doctor: Mycos-P Oral Suspension may be unsafe to use during pregnancy. Although there are limited studies in humans, animal studies have shown harmful effects on the developing baby. Your doctor will weigh the benefits and any potential risks before prescribing it to you. Doctor consultation is advised.
Seek medical advice from your doctor: Mycos-P Oral Suspension is probably unsafe to use during breastfeeding. Limited human data suggests that the drug may pass into the breastmilk and harm the baby.
Not Safe: Mycos-P Oral Suspension may cause side effects which could affect your ability to drive. As you may feel dizzy, sleepy, or have blurred vision while taking Mycos-P Oral Suspension, which may affect your ability to drive.
Caution Advised: Mycos-P Oral Suspension should be used with caution in patients with kidney disease. Dose adjustment of Mycos-P Oral Suspension may be needed. Doctor consultation is advised. Regular monitoring of kidney function tests is advised while taking this medicine. Use of Mycos-P Oral Suspension is not recommended in patients with moderate to severe kidney disease.
Safe when prescribed by an expert: Mycos-P Oral Suspension is probably safe to use in patients with liver disease. Limited data available suggests that dose adjustment of Mycos-P Oral Suspension may not be needed in these patients. Doctor consultation is advised.
What if I forget to take it?
If a dose of Mycos-P Oral Suspension is missed, take it promptly. However, if your next dose is approaching, skip the missed dose and resume your regular schedule. Avoid doubling the dose.
Manufacturer Address
LINCOLN HOUSE, B/h. Satyam Complex, Science City Road, Sola, Ahmedabad ‚ 380 062., Gujarat, India,
References
Bennett JE. Antifungal Agents. In: Brunton LL, Chabner BA, Knollmann BC, editors. Goodman & Gilmans: The Pharmacological Basis of Therapeutics. New York, New York: McGraw-Hill Medical; 2011. pp. 1581-82
Sheppard D, Lampiris HW. Antifungal Agents. In: Katzung BG, Masters SB, Trevor AJ, editors. Basic and Clinical Pharmacology. 11th ed. New Delhi, India: Tata McGraw Hill Education Private Limited; 2009. p. 841
Briggs GG, Freeman RK, editors. A Reference Guide to Fetal and Neonatal Risk: Drugs in Pregnancy and Lactation. 10th ed. Philadelphia, PA: Wolters Kluwer Health; 2015. pp. 1135-36
Medscape. Posaconazole (29 Mar. 2019)
Posaconazole. Kenilworth, New Jersey: Schering Plough; 2006 (29 Mar. 2019)
Central Drugs Standard Control Organisation (CDSCO) (29 Mar. 2019)
Noxafil (25 Jul. 2024)
Disclaimer
PlatinumRx is dedicated to delivering dependable and trustworthy information to empower our customers. However, the information presented here is solely for general informational purposes and should not be utilized for diagnosing, preventing, or treating health issues. It is not intended to establish a doctor-patient relationship or serve as a substitute for professional medical advice.
